Kaire DD as of 6/28/01ø
KAHI web page
kaireholdingsinc.com
KAIRE provides specialty pharmacy care to selected chronic disease communities through its Classic Care Pharmacy and YesRx Health Advocate programs. Patients include retired seniors living in extended care facilities and HIV patients. Additionally, Stason Biotech, a Kaire investment, is engaged in the research and development of compounds and testing measures for the treatment of pathogenic viral infections as well as other clinical applications related to solid form prescription drug formation. Stason Biotech also provides quantitive laboratory analysis to research facilities engaged in regional blood flow studies under laboratory conditions.
Kaire Holdings is a company expanding through the development of unique and proprietary consumer and business solutions, planned acquisitions, joint ventures and strategic relationships. Kaire is composed of online and off-line companies that offer tightly focused products and services supported by extensive content and resources for targeted market segments.
Kaire Holdings, Inc. (Kaire) is a public company listed on the NASDAQ Bulletin Board under the symbol KAHI. Since its formation in Delaware in 1986, Kaire has continuously been involved in the health care market segment as a provider of unique quantitative laboratory products and services to researchers, and specialized pharmacy care to defined disease communities.
Business Operations
Kaire's primary business is providing specialized pharmacy care to seniors living in extended care facilities through its Classic Care Pharmacy and to HIV patients through its YesRx Health Advocate Program.
YesRx Health Advocate Program
Kaire formed YesRx in November 1999 as an Internet based e-commerce pharmacy and drug store that provided a full range of traditional pharmacy and drug store services supported by extensive health related information and content. YesRx targeted the senior market segment.
In November 2000, Kaire introduced the YesRx Health Advocate Program; which targets the unique pharmacy needs of specific chronic care communities. The program currently provides specialized pharmacy care to seniors living in extended care facilities and HIV patients. The program focuses on service. Health Advocate team members perform a range of services well beyond that of an average pharmacy. To begin, HIV Health Advocates typically come from the communities they serve. They process a comprehensive understanding and working knowledge of the disease and its treatments. They are counselors, they facilitating communication between patients and their physicians, they help patients comply with their medication regimes, they manage patient insurance claims, and more. Many times an individual Health Advocate becomes a valued and trusted member of a patient's family.
The Health Advocate program is based at Classic Care Pharmacy in Los Angeles. From that location the program serves HIV patients in Los Angeles and Orange counties in Southern California.
Classic Care Pharmacy
Kaire acquired Classic Care Pharmacy in May 2000. Formed in 1997, Classic Care Pharmacy began operations as a provider of specialized pharmacy care for retired seniors living in extended care facilities in Los Angeles, California. Since that time, Classic Care has steadily increased the number of facilities and patients it serves.
Classic Care provides specialized services for seniors managing complex medication regimes and chronic health conditions. Many times, the elderly are required to take numerous medications daily. In those cases, compliance becomes a crucial matter for the patient as well as the facility caring for the patient. Classic Care fills prescriptions utilizing a computerized system which labels and codes individual patient medications, which are then sealed in single dose packets. This system helps reduce the chance of a patient experiencing an adverse drug reaction due to non-compliance while also increasing the time facility care providers have to spend with their patients. Services include daily delivery and management all patient insurance billing claims. Classic Care serves southern California facilities in Los Angeles, Hollywood, Long Beach, Ventura, North Hollywood, Van Nuys, Reseda, Oxnard and other locations. Classic Care serves as the primary fulfillment center for all of Kaire's specialized pharmacy care operations.
Stason Biotech
In May of 2000, Kaire entered into a Letter of Intent with Stason USA, Inc, which outlined a plan to merge Kaire's EZ-Trac Microspheres and Investigator Partner Service laboratory business with a similar business operated by Stason into a new entity, which will become a publicly reporting company. In January 2001, Kaire and Stason finalized an agreement based on the Letter of Intent and formed Stason BioTech. Kaire owns 40% of Stason BioTech.
Initially, Stason BioTech will be engaged in the research and development of compounds and testing measures for the treatment of pathogenic viral infections and other medical applications related to solid form prescription drug formation as well as providing contract research and development services to manufacturers of pharmaceutical drugs. In the first half of 2001, Stason Biotech will focus on:
Completion of an independent audit.
Developing the products and services it will offer.
Stason is now completing the independent audit and forming strategic business and market plans.
Kaire believes strongly in the Internet as a delivery and marketing platform for its specialized products and services, and it intends to exploit the full potential of the Internet as it pursues an aggressive expansion and development strategy.
The .com Pharmacy
yesrx.com
now in Espanol
farmaciayesrx.com
the new yahoo store
shop.store.yahoo.com
The Stason Biotech site (still under CONSTRUCTION )as of 1/31/00
stasonbiotech.com
Link to Stason's site:
stason.com
Kaire;s IR firm and a few interviews with the CEO
www.ceocast.com
Press Announcements
kaireholdingsinc.com
Stock Listing & General Info
Authorized Shares: 400,000,000
Issued and outstanding: 126,765,033 (3-31-01)
Active Public Float: 95,000,000 (approx. assumption)
Recent Price: $0.045 (04-17-01)
52-Week Bid/Ask Range: $0.024 - $0.600
Class of Stock: One class of common stock.
Most current Ceocast chat with Steve Westlund
kaireholdingsinc.com
UpDated 2/21/01
most current FAQ with Steve Westlund
3/10/01
ragingbull.lycos.com
ragingbull.lycos.com
more here from 2/6/01
ragingbull.lycos.com
ragingbull.lycos.com
ragingbull.lycos.com
ragingbull.lycos.com
ragingbull.lycos.com
ragingbull.lycos.com
ragingbull.lycos.com
from Friday, 22 Dec 2000
ragingbull.altavista.com
ragingbull.altavista.com
News and PRs.
Kaire Holdings Announces That Its Classic Care Division Added a Record 350 New Beds Last Week
LOS ANGELES--(BW HealthWire)--June 28, 2001--Kaire Holdings Inc. (OTCBB:KAHI - news) announced that its Classic Care division added a record 350 new geriatric and psychiatric beds last week.
Kaire Holdings Chairman and CEO Steven R. Westlund stated: ``Generally, Classic Care's marketing cycle begins in June and lasts until November. We are pleased that in our first week of marketing efforts, we landed a record number of new beds. Moreover, these particular beds are in perhaps the most profitable segment of the long-term care market.''
Westlund added, ``The additional beds bring the total number of the beds that Classic Care services on a revolving monthly basis to more than 5,500 beds in more than 70 facilities throughout Southern California.''
The company also wishes to correct the language of its news release dated June 13. Whereas the news release stated, ``Classic Care Pharmacy Has Been Chosen to Provide Prescriptions for 86 Hospice Facilities Throughout California,'' should have stated, ``Classic Care Pharmacy has Contracted to Fill Prescriptions for Roze Room Hospice, a Hospice Agency Serving Patients and Their Families at Home and in Facilities Throughout the Greater Los Angeles Area.''
About Kaire Holdings
Kaire provides specialty pharmacy care to selected chronic disease communities through its Classic Care Pharmacy and YesRx Health Advocate programs. Patients include retired seniors living in extended-care facilities and HIV patients.
Additionally, Stason Biotech, a Kaire investment, is engaged in the research and development of compounds and testing measures for the treatment of pathogenic viral infections, as well as other clinical applications related to solid form prescription drug formation. Stason Biotech also provides quantitative laboratory analysis to research facilities engaged in regional blood flow studies under laboratory conditions.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the ``act''). In particular, when used in the preceding discussion, the words ``estimated,'' ``believe,'' ``optimistic,'' ``expect'' and similar conditional expressions are intended to identify forward-looking statements within the meaning of the act and are subject to risks and uncertainties, and actual results could differ materially from those expressed in any forward-looking statements. Such risks and uncertainties include, but are not limited to, unfavorable market conditions, increased competition, limited working capital, failure to implement business strategies, and other risks. For other company information, visit the corporate Web site at www.kaireholdingsinc.com.
--------------------------------------------------------------------------------
Contact:
CEOcast Inc., New York
Mathew Henderson, 212/732-4300
www.KaireHoldingsInc.com
www.CEOcast.com
Tuesday June 19, 9:31 am Eastern Time
Press Release
Classic Care Pharmacy, a Division of Kaire Holdings, Announces Signing of a Cross-Marketing Agreement With Infinity Health Care, a Leading Mental Health Services Company
LOS ANGELES--(BUSINESS WIRE)--June 19, 2001--Kaire Holdings Inc. (OTCBB: KAHI - news) reported that its Classic Care division has signed a cross-marketing agreement with Infinity Health Care, a privately held California corporation, and a leading mental health services management company.
Kaire Holdings Chairman and CEO Steven R. Westlund stated, ``We are very excited about the Infinity Health Care contract which will give Classic Care additional access to provide pharmaceutical services to a variety of long-term care facilities. The cross-marketing campaign, which has already begun, will allow Classic Care to market its products and services to over 53 board-and-care, retirement, rehabilitation and locked psych facilities totaling over 680 beds. Classic Care will begin servicing these facilities effective immediately.''
About Infinity Health Care
Infinity Health Care, a privately held California corporation, is a provider of psychological services, psychosocial and behavioral management services, and is a licensed provider of multi-disciplinary health care continuing education in California, Nevada, Arizona, New Jersey, Connecticut, Florida and New York.
About Kaire Holdings
Kaire provides specialty pharmacy care to selected chronic disease communities through its Classic Care Pharmacy and YesRx Health Advocate programs. Patients include retired seniors living in extended care facilities and HIV patients. Additionally, Stason Biotech, a Kaire investment, is engaged in the research and development of compounds and testing measures for the treatment of pathogenic viral infections, as well as other clinical applications related to solid form prescription drug formation. Stason Biotech also provides quantitative laboratory analysis to research facilities engaged in regional blood flow studies under laboratory conditions.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the ``act''). In particular, when used in the preceding discussion, the words ``estimated,'' ``believe,'' ``optimistic,'' ``expect'' and similar conditional expressions are intended to identify forward-looking statements within the meaning of the act and are subject to risks and uncertainties, and actual results could differ materially from those expressed in any forward-looking statements. Such risks and uncertainties include, but are not limited to, unfavorable market conditions, increased competition, limited working capital, failure to implement business strategies, and other risks. For other company information, visit the corporate Web site at www.kaireholdingsinc.com.
--------------------------------------------------------------------------------
Contact:
CEOcast Inc., New York
Mathew Henderson, 212/732-4300
www.KaireHoldingsInc.com
www.CEOcast.com
Email this story - Most-emailed articles - Most-viewed articles
Wednesday June 13, 6:04 am Eastern Time
Press Release
Kaire Holdings Announces That Classic Care Pharmacy Has Been Chosen to Provide Prescriptions for 86 Hospice Facilities Throughout California
LOS ANGELES--(BW HealthWire)--June 13, 2001--Classic Care Pharmacy, a division of Kaire Holdings Inc. (OTCBB:KAHI - news), reported that it has entered into an agreement with Roze Room, a Joint Commission-accredited hospice care provider and division of L&A Care Corp., a privately held company, to provide and manage prescription services for all of Roze Room's 86 hospice care facilities throughout California.
The contract also allows Classic Care to cross-market additional Classic Care products and services to Roze Room customers.
Kaire Holdings Chairman and Chief Executive Officer Steven R. Westlund stated: ``We are pleased to announce that we have landed the Roze Room hospice contract. This agreement is further evidence of the institutional growth that our Classic Care division has experienced over the past year.
``We look forward to working with Roze Room and to giving their accounts the kind of value-added service that Classic Care customers have grown to appreciate and expect.''
About Kaire Holdings
Kaire provides specialty pharmacy care to selected chronic disease communities through its Classic Care Pharmacy and YesRx Health Advocate programs. Patients include retired seniors living in extended care facilities and HIV patients.
Additionally, Stason Biotech, a Kaire investment, is engaged in the research and development of compounds and testing measures for the treatment of pathogenic viral infections, as well as other clinical applications related to solid form prescription drug formation. Stason Biotech also provides quantitative laboratory analysis to research facilities engaged in regional blood flow studies under laboratory conditions.
Kaire Holdings Announces Record First Quarter Revenues and Continued Expansion of Its Specialized Pharmacy Care Businesses
Company Reports 45% Sequential Revenue Growth
LOS ANGELES--(BUSINESS WIRE)--May 14, 2001-- Kaire Holdings Inc. (OTCBB:KAHI - news) reported record revenues for its first quarter ended March 31, 2001, of $3,777,038, which represents a $720,000, or 45% increase, over fourth quarter 2000 sales.
The company also reported gross profit from operations of $661,698.
The company reported EBIT of ($115,099), as a result of non-recurring operating expenses at its YesRx.com e-commerce retail pharmacy. The company had a net loss of $507,429, with YesRx.com retail e-commerce pharmacy operations accounting for approximately $490,000. The balance is attributed to depreciation and interest on convertible notes.
``This quarter marks the third straight quarter that Kaire has reported record revenues and sequential revenue growth over the previous calendar quarter,'' said Steve Westlund, Kaire's chief executive officer. ``During the previous year, we identified where the greatest profit opportunities are and have taken the appropriate actions to capitalize on them.
``We see continued strong growth from our specialized pharmacy care businesses for HIV patients and seniors, and will tighten our focus, concentrating increasingly on those areas.
``Additionally, we have completed the scaling back of our retail e-commerce pharmacy operations. The benefit of those measures will be seen in this second quarter. Looking ahead, YesRx.com will serve as the primary marketing and organizational platform for the Health Advocate programs, providing patients with specialized pharmacy care and support content, as well as coordinating those operations.
``For the immediate future, the company will offer over the counter drug store products though its online store at Yahoo.com. The company expects to re-introduce a cost effective YesRx.com soon.
``We have taken additional aggressive measures to further reduce operating expenses by moving all operations into one centralized location at the company's Classic Care fulfillment center in west Los Angeles. The company anticipates this action will reduce operating expenses further by eliminating rent payments for the North Hollywood, California facility, which housed all Internet and retail e-commerce pharmacy operations, and by the elimination of duplicate staff and associated expenses required to operate multiple facilities.''
2001 Guidance
``We expect to gain additional operating efficiencies through the continuous monitoring of results versus operating expenses as we continue to implement our aggressive expansion strategy,'' said Westlund. ``For the immediate future, we see the majority of our growth coming from the expansion of internal programs. We do not anticipate making any new acquisitions until such time as market conditions have turned in the company's favor.
``Overall, we believe the company has solidified its previous accomplishments and is well positioned to move aggressively forward.''
Westlund is currently featured in an interview at www.ceocast.com, where he discusses the company's financial growth and outlook for the balance of the year.
Kaire Holdings Expands Senior and HIV Health Advocate Programs
LOS ANGELES--(BUSINESS WIRE)--April 18, 2001--Kaire Holdings, Inc. (OTCBB:KAHI - news) announced today that it plans to expand its senior and HIV Health Advocate Programs.
ADVERTISEMENT
The Program currently operates in Los Angeles, but the company plans to expand into Orange, San Diego and San Bernardino counties in southern California.
Kaire plans to support the expansion by utilizing its existing infrastructure on the Internet. The HIV Health Advocate Program has been growing rapidly and recently surpassed $1 million in annualized revenues.
``We believe that there are compelling opportunities for growth in our HIV Health Advocate Group,'' said Steve Westlund, Kaire Chairman and CEO. ``Although we have only been operating this business since November, we have already seen rapid adoption as a result of the specialized care that each patient receives. We feel quite confident that as we continue to expand that we will be able to replicate the results we have already achieved locally.''
About Kaire Holdings Inc. |
